SAN DIEGO (AP) — SAN DIEGO (AP) — Arcturus Therapeutics (ARCT) on Tuesday reported a loss of $16.2 million in its third quarter.
The San Diego-based company said it had a loss of 61 cents per share.
The pharmaceutical company posted revenue of $45.1 million in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected $27.6 million.
Arcturus Therapeutics shares have risen 14% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $19.33, a climb of 6% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARCT at https://www.zacks.com/ap/ARCT